Breaks Categories: Stock Spotlights

ThursdayJan 12, 2017 2:13 pm

NetworkNewsBreaks – BioLargo, Inc. (BLGO) on Cusp of Commercial Betas of AOS Filter System

BioLargo (OTCQB: BLGO) is a science and technology company that, for the last decade, has continued to innovate sustainable, disruptive technology-based science products designed to help solve problems threatening the world’s supply of water, food, agriculture, health care and energy. As an “invention” company, BioLargo and its subsidiaries deliver impactful products and services featuring BioLargo® Technology for both regulated and unregulated uses and applications. Last fall, the company announced the completion of the alpha unit of its advanced water treatment system - the AOS Filter (advanced oxidation system) – for applications ranging from food and agriculture to ballast water treatment.…

Continue Reading

WednesdayJan 11, 2017 3:33 pm

NetworkNewsBreaks – Guitammer (GTMM) Reports 475% Increase in FY2016 ButtKicker® Sales; Says 2017 Will Be Even Better

Reporting a triple-digit sales increase of its ButtKicker®-equipped cinema seats for full-year 2016, The Guitammer Company (OTCQB: GTMM) forecasts that its performance in 2017 will be even stronger. The Ohio-based company yesterday said it sold over 11,300 new ButtKicker®-equipped cinema seats for 57 new auditoriums in 2016, marking a 475% increase compared to 12 auditoriums and over 2,500 seats in 2015. There are now more than 20,000 ButtKicker-enabled seats in over 105 cinema auditoriums worldwide. The company also guided for continued growth this year, and said it expects to ship ButtKicker products for 1,000 seats in five new auditoriums by…

Continue Reading

WednesdayJan 11, 2017 3:26 pm

NetworkNewsBreaks – Petrogas (PTCO) Shares Climb on Acquisition of Fractional Interest in Texas

Shares of Petrogas Company (OTC: PTCO) are up 9% after the company said it has acquired a fractional interest in 11 oil and gas wells operated by Vanguard Operating (NASDAQ: VNR) in Cherokee County, Texas. Only some of the wells are currently producing hydrocarbons. "This is the type of acquisition we love to make as most of these wells had their production turned off in 2014 when oil prices began sliding. Now that prices are coming back to profitable levels, we expect that all offline wells could be brought back to production with minimal effort over the coming months," Petrogas…

Continue Reading

WednesdayJan 11, 2017 2:38 pm

NetworkNewsBreaks – Ironclad Performance Wear (ICPW) Strategizes to Buck Impact of Oil & Gas Uncertainties

Ironclad Performance Wear (OTCQB: ICPW) designs and manufactures work wear for various construction, do-it-yourself, industrial, sporting goods, and general services markets – a focus that generated third quarter 2016 sales of $6.45 million, up 19.1% year-over-year. The company specializes in task-specific gloves, such as the KONG® original, which was co-developed by the oil and gas industry safety committee for use in oil and gas drilling, extraction and refining, fracking, and many other construction-related fields. On the same note, Ironclad is hedging itself against struggles of the current oil and gas market, focusing on expansion in other key segments. To learn…

Continue Reading

WednesdayJan 11, 2017 2:30 pm

NetworkNewsBreaks – Sangamo Therapeutics, Inc. (NASDAQ: SGMO): FDA Grants Orphan Drug Designation for SB-318

Sangamo Therapeutics (NASDAQ: SGMO) is trading higher this morning on news the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company’s SB-318, a genome editing product candidate for the treatment of Mucopolysaccharidosis Type I (MPS I), a rare lysosomal storage disorder. The FDA grants orphan drug designation to drugs and biologics intended to treat rare diseases, providing incentives to advance development of rare disease drugs as well as commercialization of drugs that progress to approval. Sangamo also noted its plans to “conduct the first ever in vivo genome editing clinical trials including Phase 1/2 studies…

Continue Reading

TuesdayJan 10, 2017 3:01 pm

NetworkNewsBreaks – Biocept, Inc. (NASDAQ: BIOC) Shares Surge on Coverage Agreement with Blue Cross Blue Shield of Texas

Shares of Biocept (NASDAQ: BIOC) are up 15% on word the molecular diagnostics company has obtained an in-network provider agreement with Blue Cross Blue Shield of Texas (BCBSTX). The company views the achievement as a milestone in expanding coverage for its Target Selector™ platform, as BCBSTX is the largest provider of health benefits in Texas. "Partnering with health insurers is a major focus of our business strategy, as it may increase physician access to this non-invasive technology for their patients and provide timely adjudication of claims for patients. Securing this in-network agreement is an important milestone for Biocept, as Texas…

Continue Reading

TuesdayJan 10, 2017 1:25 pm

NetworkNewsBreaks – Pluristem (NASDAQ: PSTI) Receives FDA Clearance for Phase 3 PLX-PAD Cells Study; Shares Higher

Shares of Pluristem Therapeutics (NASDAQ: PSTI) are up 7% mid-morning following news that the FDA has cleared the company’s phase 3 study of its PLX-PAD cells in the treatment of critical limb ischemia (CLI). Patients with CLI are at an immediate risk for limb amputation and death, and with meager treatment options, have a severe unmet medical need. The company said it intends to use the results of its study to submit a biologics license application to the FDA for marketing approval. The study is expected to begin patient enrollment in both the U.S. and Europe by June 2017.  “We…

Continue Reading

FridayJan 06, 2017 1:39 pm

NetworkNewsBreaks – Identiv, Inc. (NASDAQ: INVE), NXP Semiconductors (NASDAQ: NXPI) Partner to Provide Smart Badges for CES 2017

Identiv (NASDAQ: INVE), a provider of radio frequency ID (RFID) inlays, has partnered with NXP Semiconductors N.V. (NASDAQ: NXPI) to provide RFID-inlayed badges to the 170,000+ attendees of the ongoing CES 2017 tradeshow in Las Vegas. Identiv’s high-end high-quality inlay is designed exclusively for NXP’s MIFARE DESFire EV2 state-of-the-art platform. The combined technologies enable CES attendees to quickly and securely share contact details, as well as use their badge to get into events, ride the Las Vegas Monorail, and access bike-sharing services. “Together with NXP, we are bringing fast, reliable, and safe access and transportation to all attendees during the…

Continue Reading

ThursdayJan 05, 2017 1:45 pm

NetworkNewsBreaks – Cytori (NASDAQ: CYTX) Continues to Advance Cytori Cell Therapy Clinical Trial

Cytori Therapeutics (NASDAQ: CYTX) continues to move forward with its Cytori Cell Therapy™ program, and in mid-December enrolled and treated more than half of the 45 patients in its ADRESU trial in Japan to study the efficacy and safety of Cytori Cell Therapy™ in men with stress urinary incontinence after prostatic intervention for prostate cancer or benign prostatic hypertrophy. Cytori Cell Therapy™ is being developed as a therapy to be delivered in a single treatment, designed to avoid the need for frequent re-treatment. The company reports that the therapy has thus far been well-tolerated and that it expects full enrollment…

Continue Reading

ThursdayJan 05, 2017 1:43 pm

NetworkNewsBreaks – eXp World Holdings, Inc. (EXPI) Optimistic as U.S. Housing Hits Record High of $29.6T

Investor confidence in the real estate industry was strong in 2016, evidenced by Zillow research (http://nnw.fm/Qyi23) that shows the value of U.S. housing stock increased to a record $29.6 trillion for the year, up nearly 6% over 2015. Though rising interest rates are likely to yield an unfavorable impact for homebuyers in 2017, eXp World Holdings (OTCQB: EXPI) remains optimistic about its own performance amid the changes. “Most recently, RISMedia (http://nnw.fm/l7zcS) published a study highlighting the fact that more real estate executives are confident about their own local economies than about the world economy. Yet many real estate executives are…

Continue Reading